Enovis Completes Acquisition of LimaCorporate S.p.A

WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it closed the acquisition of LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions. Lima strengthens Enovis’ position in the global orthopedic reconstruction […]

Read More »

HqO Further Propels Global Commercial Real Estate Transformation with Launch of ‘Best Spaces to Work in London’

World’s First Certification Programme for Unparalleled Workplace Experiences LONDON, Jan. 03, 2024 (GLOBE NEWSWIRE) — HqO, the world’s leading real estate experience platform, today announced the launch of ‘2024 Best Spaces to Work in London’, the only recognition and certification programme dedicated to scoring and validating end-user real estate experiences in spaces across the city. […]

Read More »

Sweegen Triumphs in Federal Court Appeal, Securing Victory Against PureCircle

Foothill Ranch, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Sweegen, the global leader in pioneering wellness ingredient and taste modulation technologies, announced a landmark victory in the U.S. Court of Appeals for the Federal Circuit, which has sided with Sweegen and affirmed the invalidation of PureCircle’s patents covering the highly sought-after stevia sweetener Rebaudioside M […]

Read More »

Junshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC Patients

SHANGHAI, China, Jan. 02, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the supplemental new drug application (the “sNDA”) for toripalimab (trade name: TUOYI®, product code: JS001) in combination with chemotherapy […]

Read More »